Abbonarsi

Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system - 03/02/21

Doi : 10.1016/j.ajem.2020.12.009 
Theodoros V. Giannouchos, PhD, MS a, , Joseph Biskupiak, PhD, MBA a, Michael J. Moss, MD b, c, Diana Brixner, PhD, RPh a, Elena Andreyeva, PhD d, Benjamin Ukert, PhD d
a Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America 
b Division of Emergency Medicine, Department of Surgery, University of Utah, Salt Lake City, UT, United States of America 
c Utah Poison Control Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America 
d Department of Health Policy & Management, School of Public Health, Texas A&M University, College Station, TX, United States of America 

Corresponding author at: Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, UT, 30 South 2000 East, Salt Lake City, UT 84112, United States of America.Pharmacotherapy Outcomes Research CenterCollege of Pharmacy, University of UtahSalt Lake City, UT, 30 South 2000 EastSalt Lake CityUT84112United States of America

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

The coronavirus disease 2019 (COVID-19) pandemic has critically affected healthcare delivery in the United States. Little is known on its impact on the utilization of emergency department (ED) services, particularly for conditions that might be medically urgent. The objective of this study was to explore trends in the number of outpatient (treat and release) ED visits during the COVID-19 pandemic.

Methods

We conducted a cross-sectional, retrospective study of outpatient emergency department visits from January 1, 2019 to August 31, 2020 using data from a large, urban, academic hospital system in Utah. Using weekly counts and trend analyses, we explored changes in overall ED visits, by patients' area of residence, by medical urgency, and by specific medical conditions.

Results

While outpatient ED visits were higher (+6.0%) in the first trimester of 2020 relative to the same period in 2019, the overall volume between January and August of 2020 was lower (−8.1%) than in 2019. The largest decrease occurred in April 2020 (−30.4%), followed by the May to August period (−12.8%). The largest declines were observed for visits by out-of-state residents, visits classified as non-emergent, primary care treatable or preventable, and for patients diagnosed with hypertension, diabetes, headaches and migraines, mood and personality disorders, fluid and electrolyte disorders, and abdominal pain. Outpatient ED visits for emergent conditions, such as palpitations and tachycardia, open wounds, syncope and collapse remained relatively unchanged, while lower respiratory disease-related visits were 67.5% higher in 2020 relative to 2019, particularly from March to April 2020. However, almost all types of outpatient ED visits bounced back after May 2020.

Conclusions

Overall outpatient ED visits declined from mid-March to August 2020, particularly for non-medically urgent conditions which can be treated in other more appropriate care settings. Our findings also have implications for insurers, policymakers, and other stakeholders seeking to assist patients in choosing more appropriate setting for their care during and after the pandemic.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : COVID-19, Emergency department, Healthcare utilization, Non-urgent visits


Mappa


© 2020  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 40

P. 20-26 - Febbraio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem
  • Kristi L. Hargrove, Ellen E. Robinson, Kathleen A. Lusk, Darrel W. Hughes, Luke A. Neff, Amanda L. Fowler
| Articolo seguente Articolo seguente
  • Is the use of greater than 1 L of intravenous crystalloids associated with worse outcomes in trauma patients?
  • Tony Zitek, Ramsey Ataya, Lian Farino, Salman Mohammed, Glenn Miller

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.